Regular aspirin use has clear benefits in reducing colorectal cancer incidence among middle-aged adults, but also comes with some risk, such as gastrointestinal bleeding. And when should adults start taking regular aspirin ...
Jan 21, 2021
0
10
A first-of-its-kind randomized clinical trial found that patients with pancreatic cancer didn't live any longer than expected after receiving pre-operative chemotherapy from either of the two standard regimens, according ...
Jan 21, 2021
0
7
In one of the first studies to examine the impact of the COVID-19 pandemic on cancer diagnoses, researchers at Dana-Farber/Brigham and Women's Cancer Center document a substantial decline in cancer and precancer diagnoses ...
Jan 14, 2021
0
2
Patients and healthcare providers at the Princess Margaret Cancer Center rated virtual care during COVID-19 as highly satisfactory overall for quality of care and convenience, while at the same time saving patients millions ...
Jan 7, 2021
0
2
(HealthDay)—From 2014 to 2019, there was a decrease in the number of medical oncologists accepting industry payments, but the per-physician payment value increased for high-value payments, according to a report published ...
Jan 4, 2021
0
3
(HealthDay)—The rate of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is 0.68 percent among patients receiving antitumor treatment, according to a research letter published online Dec. 17 in JAMA ...
Dec 28, 2020
0
8
A first-of-its-kind intervention integrating palliative care early in the course of cancer therapy for patients with advanced acute myeloid leukemia (AML), a highly aggressive cancer of the blood and bone marrow, resulted ...
Dec 17, 2020
0
2
A landmark study by researchers from the SWOG Cancer Research Network, a cancer clinical trials group funded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), has found that 2.8 percent ...
Dec 17, 2020
0
3
Cancer patients, especially newly diagnosed and African American patients, are significantly at risk for COVID-19 infection, hospitalization and mortality, according to a new study published in JAMA Oncology by researchers ...
Dec 15, 2020
0
4
The results of a large, retrospective study of patients who received a form of immunotherapy for non-small cell lung cancer (NSCLC) revealed that patients may get more than one immune-related side effect, and identified a ...
Dec 14, 2020
0
6
